Denver AI Startup Promises to End Physician 'Pajama Time' With 40-Hour Monthly Windfall
Credo Health acquires Affineon Health and relaunches as Pajama.ai, merging pre- and post-visit automation to tackle the after-hours EHR burden affecting one in three family physicians.

Denver-based healthcare AI company Credo Health has acquired Affineon Health and relaunched as Pajama.ai, unveiling an integrated ambulatory workflow automation platform designed to reclaim approximately 40 hours per physician each month. The newly combined entity made its public debut November 15-18, 2026 at the HLTH 2026 conference in Las Vegas, targeting the persistent "pajama time" phenomenon where physicians spend hours after clinic completing EHR administrative work.
According to 2026 federal data cited by the company, one in three family physicians spend three or more hours daily on after-hours chart work—a documented contributor to widespread clinician burnout. Pajama.ai's end-to-end platform aims to eliminate this burden by merging Credo's pre-visit capabilities with Affineon's post-visit automation layer.
Bridging the Pre- and Post-Visit Workflow Gap
The acquisition brings together complementary technologies that address both ends of the patient encounter. Credo's pre-visit engine automates medical record retrieval and aggregates longitudinal patient histories, while its clinical insight engine surfaces undiagnosed conditions, care gaps, overdue screenings, medication discrepancies, and abnormal trends before the appointment begins.
On the back end, Affineon's autonomous inbox workflows handle lab results, prescription renewals, and patient encounter tasks. The system automatically notifies patients of normal results and deduplicates pharmacy renewal requests—routine tasks that typically consume significant physician and staff time after hours.
Clinical validation from early adopters suggests meaningful impact. Leslie Chiang, DO, of Peachtree Medical Center, reported that Credo's pre-visit insights frequently alter clinical management decisions. Mia M. Painter, DNP, APRN, FNP-C, COO of San Marcos Family Medicine, noted that Affineon reduced inbox volume by more than 50 percent, calling it the most impactful technology implementation in years.
Leadership and Market Positioning
The combined company is led by Carm Huntress as CEO and Co-Founder, who previously founded Arrive Health. Evan Grossman, former CEO of Affineon and veteran of athenahealth, Zus Health, and Innovaccer, joins as Chief Product Officer. Financial terms of the acquisition were not disclosed.
Pajama.ai operates on a monthly subscription model integrated within existing EHR workflows, positioning itself as a comprehensive alternative to point-solution fatigue in the clinical automation market. The platform's end-to-end approach represents a strategic shift from single-feature offerings—such as standalone ambient documentation or inbox management tools—toward integrated systems spanning the entire clinical workflow.
Implications for the Health AI Landscape
This acquisition signals consolidation momentum in the ambient and administrative AI segment, where vendors are increasingly moving beyond narrow feature sets to compete with EHR-embedded solutions. The leadership team's pedigree and emphasis on EHR-native integration suggest a focus on enterprise scalability and interoperability.
For health systems and practices, the platform promises measurable reductions in administrative overhead alongside improved pre-visit preparedness that may enhance clinical decision-making. Automated care gap identification and medication reconciliation could yield downstream benefits in quality metrics, though the company's claims of 40 hours monthly reclaimed per physician will require validation across diverse practice settings.
The combination positions Pajama.ai to compete directly with comprehensive workflow automation vendors and may pressure competitors to expand their own feature sets or pursue similar consolidation strategies in an increasingly crowded market.
Sources
Companies in this article
Follow Health AI Central
Keep up with health AI where you already read
On LinkedIn
The day’s strongest health AI stories in your feed, one or two each weekday.
On Google
Choose Health AI Central as a preferred source, and Google is more likely to show our reporting in Top Stories.
Reporting & accountability
How we maintain accuracy
Health AI Central separates reported facts, analysis, and public-source data. Readers can review our standards, request a correction, or consult the relevant research methodology before relying on a claim.